A key initiative with The Mark Egly Foundation is to identify individuals who can benefit from Alpha1 Antitrypsin as a medication/supplement to allow for better health and the prevention of conditions that were previously not associated with any chain of events within the body related to the benefits of the protease inhibitor Alpha1 Antitrypsin!